Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Serum p53 antibodies in small cell lung cancer: the lack of prognostic relevance.
Jassem E, Bigda J, Dziadziuszko R, Schlichtholz B, Le Roux D, Grodzki T, Rzyman W, Konopa K, Poberezna M, Dobrzańska Z, Skokowski J, Soussi T, Jassem J. Jassem E, et al. Among authors: konopa k. Lung Cancer. 2001 Jan;31(1):17-23. doi: 10.1016/s0169-5002(00)00150-1. Lung Cancer. 2001. PMID: 11162862
(CA)n microsatellite polymorphism of ERBB-1 in breast cancer.
Wełnicka-Jaśkiewicz M, Zaczek A, Brandt B, Bielawski KP, Jaśkiewicz J, Konopa K, Jassem J. Wełnicka-Jaśkiewicz M, et al. Among authors: konopa k. Eur J Cancer. 2006 Aug;42(12):1698-701. doi: 10.1016/j.ejca.2006.03.012. Epub 2006 Jun 12. Eur J Cancer. 2006. PMID: 16765588
Assessment of EGFR Mutation Status in Matched Plasma and Tumor Tissue of NSCLC Patients from a Phase I Study of Rociletinib (CO-1686).
Karlovich C, Goldman JW, Sun JM, Mann E, Sequist LV, Konopa K, Wen W, Angenendt P, Horn L, Spigel D, Soria JC, Solomon B, Camidge DR, Gadgeel S, Paweletz C, Wu L, Chien S, O'Donnell P, Matheny S, Despain D, Rolfe L, Raponi M, Allen AR, Park K, Wakelee H. Karlovich C, et al. Among authors: konopa k. Clin Cancer Res. 2016 May 15;22(10):2386-95. doi: 10.1158/1078-0432.CCR-15-1260. Epub 2016 Jan 8. Clin Cancer Res. 2016. PMID: 26747242 Free PMC article. Clinical Trial.
An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number.
Szutowicz-Zielińska E, Konopa K, Kowalczyk A, Suszko-Każarnowicz M, Duchnowska R, Szczęsna A, Ratajska M, Sowa A, Limon J, Biernat W, Burzykowski T, Jassem J, Dziadziuszko R. Szutowicz-Zielińska E, et al. Among authors: konopa k. Oncotarget. 2017 Mar 7;8(10):17270-17278. doi: 10.18632/oncotarget.13793. Oncotarget. 2017. PMID: 27924059 Free PMC article. Clinical Trial.
25 results